M. Everts

No picture available
E-mail:
evertsm umcg.nl

Research

Publications
  1. Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity

    Heijink, A. M., Everts, M., Honeywell, M. E., Richards, R., Kok, Y. P., de Vries, E. G. E., Lee, M. J. & van Vugt, M. A. T. M., 27-Aug-2019, In : Cell reports. 28, 9, p. 2345-2357.e5 18 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

    de Boer, H. R., Pool, M., Joosten, E., Everts, M., Samplonius, D. F., Helfrich, W., Groen, H. J. M., van Cooten, S., Fusetti, F., Fehrmann, R. S. N., de Vries, E. G. E. & van Vugt, M. A. T. M., 28-Feb-2019, In : ONCOGENE. 38, 9, p. 1477-1488 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer

    Alkema, N. G., Tomar, T., van der Zee, A. G. J., Everts, M., Meersma, G. J., Hollema, H., de Jong, S., van Vugt, M. A. T. M. & Wisman, G. B. A., Jun-2014, In : Gynecologic Oncology. 133, 3, p. 591-598 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (7) »

ID: 485927